In order to increase transparency and understanding of center outcomes reporting in hematopoietic cell transplantation (HCT), CIBMTR began in 2008 to hold biannual center-specific outcomes analysis forums. CIBMTR invites representatives of the HCT community, including transplant physicians and center directors, the American Society for Transplantation and Cellular Therapy, governmental funding agencies, patients, private payers, and statisticians; the solid organ transplant community; and experts in hospital and quality outcomes reporting. The purpose is to review the current approach to center-specific outcomes reporting and to provide meaningful recommendations for future reports.